جستجوی استاد راهنمای دانشگاهی

Dr. Sabari Sankar Thirupathy serves as Assistant Professor Grade I in the School of Biology at the Indian Institute of Science Education and Research (IISER) Thiruvananthapuram since June 2017. His research program investigates fundamental mechanisms of mutagenesis with implications for genome stability, evolution, and antibiotic resistance using bacterial model systems. Ph.D. (Dr. rer. nat) 2008, Institute for Genetics, University of Cologne, Germany M.Sc. 2003, Madurai Kamaraj University, Tamilnadu, India B.Sc. 2001, The American College, Madurai Kamaraj University, Tamilnadu, India Dr. Thirupathy's research centers on replication-transcription conflicts as primary drivers of genomic instability and spontaneous mutations. His lab employs integrated approaches combining bacterial genetics, molecular biology, experimental evolution, and next-generation sequencing to dissect how collisions between replication and transcription machineries cause mutagenesis in rapidly dividing cells. This work provides critical insights into evolutionary processes, antibiotic resistance development, and disease mechanisms. His publication record (2009-2020) reveals a consistent trajectory from characterizing specific bacterial operons to elucidating universal mechanisms of mutation induction. Key themes include replication-transcription collision dynamics, mutagenesis pathways in Escherichia coli , and evolutionary implications of genomic instability, with high-impact contributions in journals like Nature and PLOS Genetics . Major recognitions include the DBT/Wellcome Trust India Alliance Intermediate Fellowship (2018), Best Poster Award at the 2016 Molecular Genetics of Bacteria and Phages Meeting, and multiple prestigious fellowships during his doctoral and postdoctoral training. Current advisees: 3 Integrated PhD students (including 2 Prime Minister's Research Fellows) and 6 Master's students Active funding: DBT/Wellcome Trust India Alliance Basic Biomedical Research Intermediate Fellowship Past mentorship: 6 undergraduate research projects (2019-2021) and Junior Research Fellow He leads The Mutations Lab at IISER TVM, which maintains specialized bacterial genetics and molecular biology facilities for studying replication-transcription conflicts. The team collaborates internationally with institutions including University of Wisconsin-Madison and Baylor College of Medicine, focusing on how collision-induced genomic instability drives evolutionary adaptation and antibiotic resistance.

• Replication-Transcription Conflicts
• Mutagenesis
• Antibiotic Resistance
• +۴ مورد دیگر

Davide Cacchiarelli is an Associate Investigator at TIGEM (Telethon Institute of Genetics and Medicine) and holds the position of "Rita-Levi Montalcini" Associate Professor of Molecular Biology in the Department of Translational Medicine at the University of Naples "Federico II". He is also the "Armenise-Harvard" Principal Investigator of the Laboratory of Integrative Genomics at TIGEM. His research focuses on genomic medicine and integrative genomics, particularly on understanding the dynamics of cell fate decisions and reprogramming. Cacchiarelli obtained both his Master's Degree and Doctorate Degree in Genetics and Molecular Biology from the University of Rome "La Sapienza", where he worked on mechanisms of RNA regulation. In 2011, he moved to The Broad Institute of MIT and Harvard and The Department of Stem Cell and Regenerative Biology at Harvard University to focus on cell fate transitions and reprogramming using genomic approaches. He returned to Italy in 2017 through the Armenise Harvard Foundation Career Development Award. His research leverages an interdisciplinary approach that brings together pluripotency and stem cell biology with cellular engineering, molecular diagnostics, genomic approaches, and mathematical modeling. Cacchiarelli's work aims to understand the regulatory logic driving cell fate during human reprogramming, with the ultimate goal of improving the quality and fidelity of reprogramming strategies for regenerative medicine therapies. His lab carries out multifaceted approaches combining genomic strategies to advance our understanding of cell fate decisions in development and genetic diseases. Recent publications highlight his contributions to understanding cellular population dynamics in pluripotency, transcription factor networks in metabolism and development, and applications of single-cell genomics to disease modeling. Rita Levi-Montalcini Assistant Professorship Grant (2017-Present) Armenise Harvard Foundation Career Development Award European Research Council Starting Grant (ERC-StG) for the CellKarma project Cacchiarelli coordinates a research group at TIGEM that is funded by an ERC-StG grant. His laboratory includes postdoctoral fellows, PhD students, technicians, and bioinformaticians working collaboratively on various aspects of genomic medicine. The lab has received significant funding from multiple sources, supporting research on cell fate reprogramming and the molecular basis of rare genetic diseases. His work on the regulatory logic of cell fate decisions has important implications for regenerative medicine and understanding developmental disorders. The Laboratory of Integrative Genomics at TIGEM, led by Cacchiarelli, brings together experts in stem cell biology, genomics, bioinformatics, and molecular biology to study cell fate decisions. The team includes Antonio Grimaldi, Lorenzo Vaccaro, and Nina Tirozzi as postdoctoral fellows; Gennaro Gandolfo, Rosa De Santis, and Vanessa Rainone as PhD students; and specialized technicians and bioinformaticians. The lab utilizes cutting-edge genomic technologies and computational approaches to unravel the complex regulatory networks governing cell identity and differentiation.

• Genomic Medicine
• Integrative Genomics
• Cell Fate Transitions
• +۴ مورد دیگر

Dr. Louis Kunkel is a Professor of Genetics and Pediatrics at Harvard Medical School and Director of the Genomics Program at Boston Children's Hospital. He is an internationally recognized leader in muscular dystrophy research, renowned for discovering the dystrophin gene in 1986 and advancing therapies for neuromuscular disorders. Education: B.A., Gettysburg College; Ph.D., Johns Hopkins University Research Interests : Dr. Kunkel’s work focuses on the molecular basis of muscular dystrophies (DMD, FSHD, LGMD) using mouse and zebrafish models. His lab investigates genetic modifiers (e.g., Jagged1, DUX4), microRNA regulation (miR-486), and small molecule therapies through CRISPR-Cas9 screens and drug discovery pipelines. Publication Trends : Recent articles highlight therapeutic targets for dystrophin-deficient models, genetic modifiers in animal models, and diagnostic innovations via long-read sequencing. Subfields span DMD, FSHD, metabolic pathways, RNA processing, and translational assays. Scientific Awards : March of Dimes Prize in Developmental Biology (2009) Member, National Academy of Sciences Member, American Academy of Arts and Sciences Students & Collaborations : Former students include Anthony Monaco and Steve Boyden. Collaborations with Pfizer and global institutions (e.g., São Paulo, Lille) drive multidisciplinary projects in drug discovery and functional genomics. Labs & Teams : The Kunkel Laboratory at Boston Children’s Hospital integrates zebrafish and mouse models, iPSC-derived muscle tissues, and genomic sequencing to develop therapies. Current team members include Elicia Estrella (Genetic Counselor), Jeffrey Widrick (Muscle Physiology), and Matthias Lambert (Pharmacology).

• Genetics
• Genomics
• Neuromuscular Disorders
• +۴ مورد دیگر

Fan Liu is a Research Assistant Professor in the Department of Biochemistry and Molecular Biology at Sylvester Comprehensive Cancer Center, focusing on epigenetic mechanisms in hematopoiesis and cancer. They hold a primary appointment at the Cancer Center and investigate how epigenetic dysregulation drives malignancies like myeloid neoplasms and myelodysplastic syndrome. Research Themes: Epigenetic regulation, transcriptional dynamics, innate immunity in cancer, JAK2 signaling, PRMT5/PRC2 interactions, and blood cell development. Key Collaborations: Affiliated with Sylvester Comprehensive Cancer Center for translational cancer research. Recent publications analyze CARM1 enzymatic activity, Trim33's role in dendritic cell differentiation, and PRMT5's antagonism of PRC2-mediated repression, highlighting their work at the interface of epigenetics and immune signaling in oncology. Their studies span molecular mechanisms in hematopoietic malignancies and innovative approaches to chemotherapy resistance in melanoma.

• Epigenetics
• Hematopoiesis
• Cancer Biology
• +۳ مورد دیگر

Xi Chen, Ph.D., is Professor of Biostatistics in the Department of Public Health Sciences at the University of Miami Miller School of Medicine. He directs the Biostatistics and Bioinformatics Shared Resource and heads the Translational Statistical Bioinformatics Laboratory, driving integrated data-science approaches to cancer and Alzheimer’s disease research. Education 2006 – Ph.D. in Statistics, North Carolina State University 2004 – M.S. in Statistics, North Carolina State University 2002 – M.S. in Molecular Genetics, North Carolina State University 1999 – B.S. in Biochemistry, Lanzhou University Research Interests Dr. Chen’s work bridges advanced statistical methodology and high-throughput genomic data to tackle complex biomedical questions. Major foci include: Translational cancer research, especially biomarker discovery in triple-negative breast and colorectal cancers. Multi-omics integration—combining genomics, epigenomics, proteomics, and methylomics for systems-level insights. Predictive modeling and high-dimensional variable selection for precision medicine. Epigenomic signatures of aging and Alzheimer’s disease, leveraging large longitudinal cohorts. His lab develops reproducible computational tools and collaborates closely with bench scientists and clinicians to translate statistical findings into clinical impact. Recent Publication Trends Over the last two years Dr. Chen’s publications reveal a strategic expansion from foundational cancer genomics toward neuroepigenomics. Cutting-edge methylation-array quality control studies complement the creation of the MIAMI-AD knowledgebase, underscoring his commitment to open, integrative resources. Ongoing work on blood-based dementia biomarkers and lifestyle-resilience signatures illustrates the translational arc of his research program. Scientific Awards & Honors While the provided text does not enumerate specific awards, Dr. Chen has served as a reviewer for numerous prestigious panels including: National Cancer Institute Cancer Biomarker Study Section (CBSS) National Institute of Neurological Disorders & Stroke (NINDS) Morris K. Udall Centers of Excellence for Parkinson’s Disease Research (P50) Health and Medical Research Fund, Government of Hong Kong Grants & Collaborations Dr. Chen has directed multiple NIH-funded projects integrating gene expression, proteomic, and methylation data to identify actionable cancer biomarkers. His interdisciplinary teams include oncologists, pathologists, and computational biologists across the University of Miami and external consortia. Laboratory & Teams The Translational Statistical Bioinformatics Laboratory ( tsblab.org ) provides a collaborative hub where trainees and staff develop next-generation analytical pipelines. The lab maintains active GitHub repositories and openly shares software tools to foster reproducible research in the genomics community.

• Biostatistics
• Bioinformatics
• Translational cancer research
• +۵ مورد دیگر

Brian Lewis is a Professor and holds the George F. Booth Chair in the Basic Sciences at UMass Chan Medical School. He has multiple academic appointments across the T.H. Chan School of Medicine and the Morningside Graduate School of Biomedical Sciences, with affiliations in the Department of Molecular, Cell and Cancer Biology, Program in Molecular Medicine, Radiation Oncology, and several graduate programs including Cancer Biology, Interdisciplinary Graduate Program, MD/PhD Program, Postbaccalaureate Research Education Program, and Translational Science. Dr. Lewis received his educational training from: BS in Biology from the University of California, Los Angeles (1991) PhD in Human Genetics & Molecular Biology from Johns Hopkins University (1997) Dr. Lewis's research focuses on the molecular genetics of pancreatic and liver cancers. His laboratory has generated innovative animal models for pancreatic cancer using the RCAS-TVA gene delivery system, which allows for tissue-specific expression of oncogenes. His work explores the complex relationships between specific genetic alterations, tumor behavior, and signal transduction pathways in cancer development and progression. A key aspect of his research involves understanding how particular genetic changes influence tumor initiation, progression, and metastasis in pancreatic and hepatic carcinomas. His work has significant implications for developing targeted cancer therapies based on understanding underlying molecular defects, similar to the success of Imatinib (Gleevec) in other cancers. Analysis of Dr. Lewis's recent publications reveals a strong focus on pancreatic cancer mechanisms, particularly examining the roles of oncogenes like KRAS and signaling pathways including Wnt, Hedgehog, and IGF1R. His research consistently explores how genetic alterations such as p53 deletion cooperate with other mutations to drive tumor progression and metastasis. His work bridges basic molecular mechanisms with potential therapeutic applications, investigating how understanding these pathways could lead to more effective cancer treatments. Dr. Lewis has received several notable scientific awards: Burroughs Wellcome Fund Career Development Award in the Biomedical Sciences Helen Hay Whitney Foundation postdoctoral fellowship 2009 recipient of the Pancreatic Cancer Action Network-AACR Pilot Grant for "Involvement of miRNAs in Kras-Induced Pancreatic Tumorigenesis" As a principal investigator, Dr. Lewis has mentored numerous students and researchers in his laboratory at the Lazare Research Building. His research is supported by competitive grants including the Burroughs Wellcome Fund Career Development Award and the Pancreatic Cancer Action Network-AACR Pilot Grant. His work contributes significantly to the UMass Chan Pancreas Program, a multidisciplinary initiative focused on advancing pancreatic cancer treatment through integrated basic science and clinical research. Dr. Lewis leads a research laboratory within the UMass Chan Pancreas Program, which is part of a larger collaborative effort involving surgical oncology, medical oncology, radiation oncology, gastroenterology, and other specialties. His basic science research complements the clinical work of the program, creating a comprehensive approach to understanding and treating pancreatic cancer. His laboratory specializes in developing and utilizing novel mouse models to study pancreatic and liver cancer pathogenesis, with particular expertise in the RCAS-TVA gene delivery system.

• Molecular Genetics of Pancreatic Cancer
• Molecular Genetics of Liver Cancer
• Signal Transduction Pathways
• +۷ مورد دیگر

Asifa Akhtar serves as Scientific Member and Director at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg and holds an Honorary Professorship at the University of Freiburg's Medical Faculty. She concurrently acts as Vice President of the Biology and Medicine Section of the Max Planck Society since 2020. Her academic foundation includes: PhD from Imperial Cancer Research Fund, London (1997) Postdoctoral training at EMBL Heidelberg and Adolf Butenandt Institute, Munich Dr. Akhtar's research pioneers epigenetic mechanisms through investigations of chromatin architecture, histone modifications, and long noncoding RNAs in gene expression control. Her laboratory integrates biochemical, genetic, and bioinformatic methodologies across Drosophila , murine, and human model systems to elucidate fundamental regulatory principles. Her distinguished accolades include: EMBO Membership (2013) Leopoldina Academy Membership (2019) Gottfried Wilhelm Leibniz Prize (2021) Ellis Island Medal of Honor (2023) FEBS/EMBO Women in Science Award (2025) She leads an active research group at the Max Planck Institute driving epigenetic discovery with implications for developmental biology and disease mechanisms.

• Epigenetics
• Chromatin Biology
• Gene Regulation
• +۳ مورد دیگر

Nicolas Buchler is an Associate Professor at North Carolina State University, affiliated with the Department of Molecular Biomedical Sciences and the Chancellor’s Faculty Excellence Program cluster in Modeling the Living Embryo. His research explores interactions between cell cycle and metabolic rhythms, focusing on how these interactions drive disease or novel biological functions. Education : B.S. in Physics (UC San Diego), Ph.D. in Biophysics (University of Michigan) Research Areas : Systems biology of gene networks, computational modeling of cellular dynamics, fungal/yeast cell cycle regulation Collaborations : Studies circadian clocks and regulatory systems across animals, plants, and microbes Contact: nebuchle@ncsu.edu | Office: CVM Research Building 390, Raleigh, NC | Phone: 919-515-1057

• Systems Biology
• Developmental Biology
• Computational Biology
• +۳ مورد دیگر

Professor Linda King is a leading academic at Oxford Brookes University , serving as Pro Vice-Chancellor for Research and Global Partnerships. She earned her BSc and DPhil in molecular virology from Oxford University and has been a faculty member at Oxford Brookes since 1986, ascending to Professor in 1998. Professional Memberships: Society for General Microbiology, Society for Invertebrate Pathology, Fellow of the Society of Biology Her research focuses on insect virology and biotechnology , particularly baculovirus expression systems . She pioneered the flashBAC platform for recombinant virus production and co-founded Oxford Expression Technologies Ltd , a biotech spin-out. Recent research trends include viral protein trafficking , gene therapy applications in organ transplantation, and vaccine development against zoonotic pathogens. She has secured major grants from DEFRA (£420,557) and BBSRC (£9,326) for projects like NanoZoo (2023-2026). Scientific Awards: Fellow of the Society of Biology (FRSB) As a co-founding director of OET, she drives translational research. Her work spans bioimaging and protein engineering , with over 100 peer-reviewed publications and leadership roles in virology editorial boards.

• Insect Virology
• Baculovirus Expression Systems
• Biotechnology
• +۳ مورد دیگر

Dr. Kate Lines is an Emerging Leader Research Fellow at Oxford Brookes University, School of Biological and Medical Sciences. She leads her own research group investigating epigenetic mechanisms in cancer, particularly endocrine cancers and neuroendocrine tumours (NETs). She holds a BSc(Hons) in Biochemistry from the University of Liverpool and a PhD in Molecular Oncology from the Barts Cancer Institute, with over 10 years of postdoctoral experience at the University of Oxford. Her research focuses on: Epigenetic regulation of gene expression (DNA methylation, histone organization, microRNA) in cancer Role of MEN1, ATRX, and DAXX mutations in endocrine and neuroendocrine tumors Calcium signaling pathways in pituitary tumorigenesis Development of preclinical models via the NET Models Consortium Recent publications (2022-2025) demonstrate a strong emphasis on endocrine oncology, with themes spanning epigenetic dysregulation, calcium signaling, genetic mutations (e.g., MEN1, GNAQ/GNA11), and therapeutic modeling. Over 50% of articles focus on neuroendocrine tumors, and 30% explore calcium receptor mechanisms. She holds editorial roles at Endocrine Oncology and Endocrinology Insights and serves as the UK Research Ambassador for the NET Cancer Foundation, driving public engagement in cancer research. She leads the NET Models Consortium to advance tumor modeling and collaborates internationally on endocrine cancer studies.

• Epigenetics
• Cancer Biology
• Endocrine Cancers
• +۴ مورد دیگر

Professor Rob Kingsley is a Group Leader at the Quadram Institute, specializing in pathogen variation and its implications for food safety, antimicrobial resistance, and host-microbiome interactions. His work bridges genomic and molecular microbiology to address bacterial pathogenesis and surveillance. Research Focus: Salmonella enterica, genomic epidemiology, bacteriophage resistance, and microbiome dynamics Methods: Whole-genome sequencing, transcriptomics, transposon mutagenesis, and infection models Applications: Foodborne disease prevention, AMR tracking, and therapeutic development Recent publications highlight his dual focus on bacterial pathogens like Salmonella and Listeria, as well as SARS-CoV-2 genomic surveillance. His team investigates how genomic variation drives host adaptation, phage resistance, and environmental persistence, with implications for public health and food safety. Key Collaborators: Michaela Matthews, Dr. Petros Muchesa, Nick Martin Notable Projects: Development of bacteriophage therapies, low-protein diet interventions, and adhesome analysis tools

• Salmonella enterica
• Genomics
• Antimicrobial Resistance
• +۶ مورد دیگر

Lewei Zhang serves as a Professor in the Department of Oral Biological & Medical Sciences at the University of British Columbia's Faculty of Dentistry. His research centers on oral potentially malignant disorders, with emphasis on molecular mechanisms driving malignant transformation in oral epithelial dysplasia and lichenoid lesions. Dr. Zhang's research program integrates molecular pathology , microbiome analysis , and advanced imaging techniques to develop risk assessment models for oral cancer progression. Key focus areas include E-cadherin/beta-catenin signaling pathways, p53 immunohistochemical patterns, and the diagnostic potential of oral microbiome profiling. His work bridges basic science with clinical applications through image cytometry and multiplexed immune microenvironment analysis. Analysis of his 15 most recent publications (2020-2025) reveals three dominant research trajectories: (1) molecular characterization of dysplasia progression using cell adhesion markers, (2) clinicopathological analysis of lichenoid lesions with dysplastic features, and (3) development of non-invasive diagnostic tools including microbiome-based predictors and multispectral imaging. Notable methodological innovations include brushing-based DNA ploidy analysis and quantitative pathology toolboxes for risk stratification. As a graduate supervisor in UBC's Craniofacial Science programs, Dr. Zhang mentors students in translational oral cancer research. His extensive publication record demonstrates sustained contributions to early detection protocols and molecular classification systems for oral potentially malignant disorders, with direct implications for clinical management guidelines.

• Oral Cancer
• Oral Dysplasia
• Oral Premalignant Lesions
• +۳ مورد دیگر

Robert Harrod is a Professor in the Department of Biological Sciences at Southern Methodist University, researching molecular mechanisms of viral carcinogenesis by HTLV-1 and high-risk HPVs which cause 15-20% of human cancers through deregulation of cellular growth pathways. Education: Ph.D. from University of Maryland Postdoctoral training at National Institutes of Health and USUHS/NMC Research Focus: His laboratory investigates how viral proteins (HTLV-1 p30II/Tax/HBZ and HPV E6) cooperate with cellular oncogenes like c-Myc, interact with transcriptional coactivators, and modulate p53-regulated pro-survival signals to drive cellular immortalization and tumorigenesis. Key discoveries include TIGAR's role in virus-infected tumor cell survival, identifying targets for novel therapeutics against aggressive malignancies like adult T-cell leukemia/lymphoma and cervical cancers. Publication Trends: Analysis of recent work reveals consistent emphasis on viral manipulation of oxidative stress responses (TIGAR/p53 pathways), mitochondrial targeting mechanisms, and therapeutic interventions like oleandrin. Research bridges virology, cancer biology, and molecular pharmacology with translational focus on disrupting viral carcinogenesis. Grants: Laboratory research is funded by the National Cancer Institute/National Institutes of Health. Facilities: Operates from laboratory DLSB 322 at Southern Methodist University, utilizing in vitro and in vivo xenograft models to study viral oncogenesis.

• Viral Carcinogenesis
• Oncogenic Viruses
• Molecular Biology of Viruses
• +۳ مورد دیگر

Vanessa Auld is a Professor in the Department of Zoology at the University of British Columbia's Faculty of Science. She conducts her research at the Life Sciences Institute (LSI 3358) where she leads the Auld Lab, which focuses on understanding the development and function of glial cells in the nervous system using Drosophila melanogaster as a model organism. Dr. Auld received her B.Sc. in Microbiology from the University of British Columbia and completed her Ph.D. in Medical Genetics at the University of Toronto. Dr. Auld's research program investigates the critical roles that glia play in nervous system development and function. Her lab examines how glial cells wrap, insulate, and protect the nervous system, with particular focus on three key questions: (1) What mechanisms drive glial cells to ensheathe/wrap their associated axons? (2) What proteins allow for the formation of the glial-based blood-brain barrier? (3) How do the glial layers interact with each other and the overlying extracellular matrix to support peripheral nerve sheath integrity? Her research has revealed significant parallels between Drosophila and vertebrate glia, demonstrating that disruptions in glial development can lead to loss of nervous system function, neurodegeneration, and death. Dr. Auld's recent publications reflect her ongoing investigation into glial biology, with particular emphasis on tricellular junction formation, glia-ECM interactions, and the molecular mechanisms underlying axon ensheathment. Her work spans cell biology, developmental biology, and neuroscience, with applications to understanding human neurological disorders. She has developed numerous methodological approaches for studying Drosophila nervous system development, contributing significantly to the field's technical capabilities. Dr. Auld has mentored numerous graduate students and postdoctoral fellows throughout her career. Her lab is committed to creating an inclusive research environment that values and welcomes people from diverse backgrounds and is dedicated to supporting members from groups underrepresented in the sciences. The Auld Lab is situated within the collaborative, multidisciplinary research environment of the Life Sciences Institute at UBC Vancouver. The lab acknowledges that they work on the traditional, ancestral, and unceded territory of the xʷməθkʷəy̓əm (Musqueam) people.

• Cell Biology
• Developmental Biology
• Neuroscience
• +۶ مورد دیگر

Kevin Wei is an Assistant Professor in the Department of Zoology, Faculty of Science, University of British Columbia. His research integrates genomics, evolutionary biology, molecular biology, and developmental biology to investigate how selfish genetic elements, such as transposable elements, drive genome complexity and developmental process evolution. Education: B.A. & Sc. from McGill University, Montreal, Canada Ph.D. from Cornell University, USA Postdoctoral research as an NIH K99 Fellow at University of California Berkeley The Wei lab focuses on genetic arms races between selfish elements (e.g., transposable elements, meiotic drivers) and genomic defense mechanisms. This dynamic influences genome architecture and processes like meiosis, embryogenesis, and germline development. The lab leverages the Drosophila genus's genetic and species diversity to study evolution in action, combining genomics, genetics, and population biology. Recent research trends highlight the role of transposable elements in recombination variation, epigenetic conflict, synaptonemal complex adaptation, and germline regulation. These studies often involve Drosophila as a model system, emphasizing evolutionary insights applicable across species. Scientific Awards: NIH K99 Fellow Kevin Wei actively welcomes undergraduate, graduate students, and postdocs to his lab. His lab members include M. Byars, A. Chauhan, A. Fielding, D. Sangha, H. Ye, and R. Zakerzade. The lab website kweilab.ca provides further details.

• Genomics
• Evolutionary Biology
• Molecular Biology
• +۷ مورد دیگر